Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 31 out of 100. Brain scans and imaging

Topic: Amyloid, tau and blood-test diagnosis

ABSTRACT Alzheimer's disease (AD) diagnosis using MRI scans must be very accurate since the subtle differences throughout the course of the disease are difficult to identify. Traditional approaches are not effective, and new computational techniques are required that can provide fast and accurate diagnosis. In this paper, a novel deep learning methodology that greatly enhances the sensitivity and specificity of AD stage identification by analyzing in‐depth MRI scans is proposed. The model applies a novel Sequential Convolutional Neural Network (CNN) architecture, which has been deeply trained on the “Augmented Alzheimer MRI Dataset” made available by Kaggle, to integrate various layers of depth and complexity to identify and scan in‐depth features on MRI images. Major enhancements include the use of learning rate schedulers and dropout regularization to fine‐tune training as well as avoid overfitting, with a diagnosis accuracy of 94.2%. This level of accuracy not only makes diagnostic processes easier but also allows for early detection of Alzheimer's phases, which is crucial for timely interventions and effective management of the condition. The model is rigorously trained on a large set of augmented data with varying levels of AD to guarantee robustness and generalizability in various demographic and clinical settings. Batch normalization and higher‐order activation functions allow faster and stable convergence of training, and thus the model is more efficient and scalable. Application of this model to the clinic has the potential to sharply reduce time to diagnosis, lessen dependence on radiological expertise, and offer a high‐accuracy, scalable imaging device enabling early and accurate treatment in Alzheimer's care. This innovation represents a significant next phase in medical imaging with artificial intelligence, and it offers a highly effective tool for fine detection and staging of Alzheimer's disease.

Key findings

Why it matters

This study used a deep learning model to classify stages of Alzheimer's disease from MRI scans, achieving 94.2% accuracy. It is a detection and staging method only and does not test any treatment, cure, or prevention.

Study details

How this study scored 31/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 31 of 100.31 of 100 points earned69 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Computational Intelligence)
Journal's citation record 1 / 4 Computational Intelligence: journal h-index 90 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Ahlam I. Almusharraf: h-index 19 (OpenAlex, whole career)
Institution's track record 0 / 3 University of Salford: institution h-index 305 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 5 institution(s) in 3 countries
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 31 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Chandrasekaran, S., Bhatia, S., Gupta, M., Mahesh, T. R., Alqhatani, A., & Almusharraf, A. I. (2025). Enhanced Deep Learning Framework for Precise MRI ‐Based Alzheimer's Disease Stage Classification. Computational Intelligence. https://doi.org/10.1111/coin.70123

Vancouver

Chandrasekaran S, Bhatia S, Gupta M, Mahesh TR, Alqhatani A, Almusharraf AI. Enhanced Deep Learning Framework for Precise MRI ‐Based Alzheimer's Disease Stage Classification. Computational Intelligence. 2025. doi:10.1111/coin.70123.

BibTeX

@article{chandrasekaran2025-8eadc3a2,
  author  = {Chandrasekaran, Saravanan and Bhatia, Surbhi and Gupta, Muskan and Mahesh, T R and Alqhatani, Abdulmajeed and Almusharraf, Ahlam I.},
  title   = {{Enhanced Deep Learning Framework for Precise MRI ‐Based Alzheimer's Disease Stage Classification}},
  journal = {Computational Intelligence},
  year    = {2025},
  doi     = {10.1111/coin.70123},
  url     = {https://doi.org/10.1111/coin.70123}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Brain scans and imaging

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →